Release date: 2024-08-20 16:40:55 Article From: Lucius Laos Recommended: 135
Launched in Japan in 2021, anamoline is the world's first drug specifically for the treatment of cachexia; As a ghrelin receptor agonist, it is able to increase the patient's appetite, increase body weight and muscle mass. The advent of anamoline fills a gap in the field of cancer cachexia therapy.
Anamorelin is specifically used to relieve symptoms of cancer cachexia, especially weight loss and decreased appetite caused by cancer.
It is indicated for the treatment of colorectal cancer patients, especially in support of disease-related cachexia and weight loss.
For those with cancer cachexia who do not respond well to standard nutritional therapy, anamarin can be used as a complementary treatment to help improve weight and appetite.
With effective treatment for these symptoms, anamoline helps to improve the patient's quality of life and overall well-being. It is important to understand the precautions associated with medication before using the drug.
When using anamoline, the following things can help optimize treatment outcomes and reduce potential risks.
In patients with underlying heart conditions, such as valvular disease and cardiomyopathy, anamarin may suppress heart function and worsen symptoms.
These patients may have cardiac dysfunction and symptoms may worsen.
Adhering to these precautions can help you better manage your treatment and improve its outcomes. Next, we will explore the interaction of anamarin with other drugs.
Understanding drug interactions is essential to optimize treatment and avoid potential risks. Next, we will detail the interactions that anamarin may have with other medications.
Drugs like piperacillin and hydrochloride chloride also have sodium channel inhibition, and their use in combination with Anamorelin may increase the risk of arrhythmias, requiring special attention to changes in cardiac symptoms.
Drugs such as atenolol can have a suppressive effect on cardiac function, and when used with anamolin, it may exacerbate the side effects of cardiac function suppression, and cardiac function should be closely monitored.
Having this information on drug interactions can help patients better manage their treatment and avoid unnecessary risks.
[Warm tips] Please pay attention to the compatibility with other drugs during the use of anamoline, and adjust the medication regimen in time if there is any change or discomfort.
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended:2012024-09-07
On November 14, 2024, the Committee for Medicinal Products for Human Use (CHMP) of the European Medi···【more】
Recommended:1582025-13-01
Recent advancements have reaffirmed the significance of liquid biopsy in the management of advanced ···【more】
Recommended:1562025-06-01
FDA Approves First Generic Version of Victoza (liraglutide injection)The U.S. Food and Drug Administ···【more】
Recommended:1712024-30-12
The new indication involves the treatment of adult patients with locally advanced, unresectable non-···【more】
Recommended:1612024-24-12
he U.S. Food and Drug Administration (FDA) has approved Crenessity (crinecerfont) for use in combina···【more】
Recommended:1462024-17-12
In the phase Ib/II multicenter pivotal FELIX study, the autologous 41BB-ζ anti-CD19 chimeric antigen···【more】
Recommended:1052024-13-12
On 25 July 2024, the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHM···【more】
Recommended:2482024-26-08
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp: